ILXO > ILEX Oncology > CURE for CANCER in 1999

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ILXO > ILEX Oncology > CURE for CANCER in 1999

An SI Board Since January 1999

Posts	SubjectMarks	Bans
23	9	0

Emcee: Jim K.	Type: Unmoderated

Introduction Compact

CURE for Breast, Prostate, and Lung CANCER in 1999
I believe this will be the company that will bring the CURE to MARKET.
Could be THE BIG RUN in 1999 !!!!
How about some discussion here ?
Link to Web Site > Press Releases from ILEX Oncology
ilexoncology.com
*********************************
History of ILEX Oncology:
In 1993, Dr. Daniel D. Von Hoff, Dr. Charles A. Coltman, Jr., Richard
Love, and the Cancer Therapy and Research Center (CTRC) founded ILEX for the sole purpose of bringing cancer prevention and treatment drugs to patients as quickly as possible. Drs. Von Hoff and Coltman, who have both dedicated their lives to fighting cancer, created ILEX as a spin-off of the CTRC to streamline the development process "from bench to bedside," and expedite the path of new drug therapies from inception to application.
*********************************
A Phase I study of SR-45023A in advanced metastatic cancer is underway
under the leadership of David S. Alberts, M.D., Associate Dean for
Research, College of Medicine and Arizona Cancer Center, University of
Arizona. "The novel mechanism by which SR-45023A induces apoptosis in
cancer cells puts this into a new class of agents which appears to
selectively target cancer and spares normal tissue cells," said Dr. Alberts.

The agreement calls for ILEX to conduct all future clinical development activities, for which the company has negotiated an ownership position in the compound and has the right to negotiate for all future rights to the compound.

"If the Phase I tests are successful, SR-45023A has the potential to be used broadly in many cancers," said Richard Love, ILEX president and chief executive officer. "The addition of this exciting new drug to our portfolio represents yet another step toward a balanced portfolio of products with novel mechanisms of action and significant therapeutic and commercial promise."
*********************************

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
23	Did anyone see those 9 trades this morning when a mm posted an ask of 11.25 - 1	David Loomis	-	5/24/2000
22	Trakker, It was stunning to see the stock close down on news that they still c	Ed Ajootian	-	3/26/2000
21	hopefully it's just a gap fill. looks like its rebounded to some extent. g	Trakker	-	3/20/2000
20	Trakker, Got in even _later, and bought more today at 37. Does anyone know wh	Ed Ajootian	-	3/15/2000
19	Enjoying this little move. Got in late (?) at 38. Hopefully we can expect some	Trakker	-	2/16/2000
18	Few of us hanging out enjoying the run up. RWR	RWReeves	-	1/25/2000
17	boy! this stock has chalked up 30%+ gains and nobody seems to be home. the rise	satish kamat	-	1/21/2000
16	FWIW. Took a position in ILXO @24 1/4. Interesting portfolio past CAMPATH. Wort	Larry Liebman	-	1/11/2000
15	SM - Hello, I am thinking of buying a small amount. Two questions: (1) How b	John McCarthy	-	12/23/1999
14	I'm still here :-) Campath data looks great, and I would expect them to co	StockMiser	-	12/16/1999
13	Anyone still left here? ILXO still has JV with LKST (now part of MLNM World Do	RWReeves	-	12/14/1999
12	For the terminally lazy...here is that report :) July 20, 1999 RECOMMENDATION	StockMiser	-	7/20/1999
11	SmallCapsOnline Comments on ILEX's Recent Acquisition of Convergence Pharma	BridgeTech	-	7/20/1999
10	Convergence is sold to firm Texas firm Hub company in $10m deal working on ca	StockMiser	-	7/20/1999
9	A little bit about Covergence from the Yahoo boards... Claim anti-angiogensis m	StockMiser	-	7/20/1999
8	Ilex Expects Drug Pact Soon, Buys Research Firm for $11 Mln Ilex Expects Drug	StockMiser	-	7/19/1999
7	SmallCaps Online LLC Initiates Coverage of ILEX Oncology, Inc. With a BUY Recom	BridgeTech	-	7/13/1999
6	I was wondering why no mention of the (2) products already in Phase III? Campa	StockMiser	-	6/28/1999
5	I agree. But RAT are the initials of the founder-Richard A. Thomas . I've t	telephonics	-	1/4/1999
4	RatCom!!! What a name!	chalu2	-	1/3/1999
3	What the researchers need to speed up their work is a new DNA Analysis System i	telephonics	-	1/3/1999
2	If this is in Phase I trials, it is many, many years away from the market in th	chalu2	-	1/1/1999
1	All: Some thing REAL and AFFORDABLE that has a lot of near potential, this may	Jim K.	-	1/1/1999

Go to reply# or date (mm/dd/yy):